Synonyms: FX 909 | FX909
Compound class:
Synthetic organic
Comment: FX-909 is a first-in-class oral, covalent inverse agonist of the peroxisome proliferator activated receptor gamma (PPARG) nuclear hormone receptor [1]. It was developed for anti-tumour potential. The chemical structure was disclosed during the 'First Disclosures of New Drug Candidates' session at the April 2023 (Orlando) meeting of the AACR.
|
|
No information available. |
Summary of Clinical Use |
FX-909 is a clinical candidate for solid tumours and urothelial carcinoma. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT00000189 | Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 | Phase 2 Interventional | University of Pennsylvania |